Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
暂无分享,去创建一个
Feng Gao | Bette Korber | Tongye Shen | Hui Li | William R. Schief | S. Gnanakaran | Tanmoy Bhattacharya | Alan S. Lapedes | Peter B. Gilbert | Norman L. Letvin | Brian Gaschen | Michael S. Saag | Yih-En Andrew Ban | Barton F. Haynes | Georgia D. Tomaras | Charles B. Hicks | Brandon F. Keele | George M. Shaw | Allan C. deCamp | Craig A. Magaret | Paul A. Goepfert | A. Lapedes | W. Blattner | B. Korber | P. Hraber | J. Sodroski | B. Haynes | F. Gao | Tanmoy Bhattacharya | M. Markowitz | N. Letvin | G. Shaw | L. Ping | B. Hahn | M. Saag | R. Swanstrom | M. Daniels | B. Gaschen | B. Keele | S. Gnanakaran | Y. Ban | W. Schief | P. Gilbert | P. Goepfert | J. Salazar-Gonzalez | Hui Li | J. Decker | Shuyi Wang | Myron S. Cohen | K. Soderberg | T. Shen | Chunlai Jiang | G. Tomaras | Ming Zhang | J. Eron | C. Hicks | Jeffrey A. Anderson | M. Asmal | Joseph J. Eron | Julie M. Decker | Shuyi Wang | Beatrice H. Hahn | Ronald Swanstrom | Chunlai Jiang | Martin Markowitz | Joseph G. Sodroski | Jesus F. Salazar-Gonzalez | Kelly A. Soderberg | Mohammed Asmal | Peter T. Hraber | William A. Blattner | Ming Zhang | Li-Hua Ping | Marcus Daniels | Mohan Krishnamoorthy | Allan C. DeCamp | C. Magaret | M. Krishnamoorthy | M. Cohen | Li‐hua Ping | M. Cohen
[1] 安藤 寛,et al. Cross-Validation , 1952, Encyclopedia of Machine Learning and Data Mining.
[2] Feng Gao,et al. Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120. , 2011, Virology.
[3] Q. Sattentau,et al. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. , 2010, Journal of molecular biology.
[4] Ming Li,et al. Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies , 2010, PLoS Comput. Biol..
[5] Alan S. Perelson,et al. Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing , 2010, PloS one.
[6] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[7] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[8] B. Haynes,et al. Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys , 2010, Journal of Virology.
[9] Dennis R Burton,et al. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens , 2010, Proceedings of the National Academy of Sciences.
[10] Alan S. Perelson,et al. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.
[11] Andrew K. Udit,et al. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. , 2010, Chemistry & biology.
[12] Winston A Hide,et al. Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. , 2010, Virology.
[13] B. Korber,et al. HIV-1 vaccine development after STEP. , 2010, Annual review of medicine.
[14] Persephone Borrow,et al. The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.
[15] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[16] Tanmoy Bhattacharya,et al. Modeling sequence evolution in acute HIV-1 infection. , 2009, Journal of theoretical biology.
[17] Tongqing Zhou,et al. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.
[18] Polung Yang,et al. The Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 Harbors Lipid Raft Association Determinants , 2009, Journal of Virology.
[19] S Gnanakaran,et al. The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility , 2009, Current opinion in HIV and AIDS.
[20] S. Gnanakaran,et al. Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways , 2009, PLoS pathogens.
[21] Lynn Morris,et al. Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection , 2009, PLoS pathogens.
[22] L. Lopalco,et al. Abundant and Superficial Expression of C-Type Lectin Receptors in Ectocervix of Women at Risk of HIV Infection , 2009, Journal of acquired immune deficiency syndromes.
[23] A. Perelson,et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.
[24] Alan S. Perelson,et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.
[25] Xiping Wei,et al. Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection1 , 2009, The Journal of Immunology.
[26] Alan S. Perelson,et al. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 , 2009, The Journal of experimental medicine.
[27] Bette Korber,et al. HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC , 2009, PLoS pathogens.
[28] Wei Huang,et al. Selection of HIV variants with signature genotypic characteristics during heterosexual transmission. , 2009, The Journal of infectious diseases.
[29] R. Swanstrom,et al. Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants , 2009, Journal of Virology.
[30] Cynthia A. Derdeyn,et al. Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 , 2009, PLoS pathogens.
[31] Kazutaka Katoh,et al. Multiple alignment of DNA sequences with MAFFT. , 2009, Methods in molecular biology.
[32] J. Margolick,et al. Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals , 2008, Journal of Virology.
[33] K. Van Laethem,et al. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention. , 2008, Virology.
[34] John R. Mascola,et al. Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals , 2008, Journal of Virology.
[35] Lynn Morris,et al. Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C , 2008, Journal of Virology.
[36] J. Mullins,et al. Evolution of CCR5 Use before and during Coreceptor Switching , 2008, Journal of Virology.
[37] E. Go,et al. Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein , 2008, Journal of the American Society for Mass Spectrometry.
[38] R. Desrosiers,et al. Potent Antibody-Mediated Neutralization and Evolution of Antigenic Escape Variants of Simian Immunodeficiency Virus Strain SIVmac239 In Vivo , 2008, Journal of Virology.
[39] Critical issues in mucosal immunity for HIV-1 vaccine development. , 2008, The Journal of allergy and clinical immunology.
[40] Hui Li,et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.
[41] J. Mullins,et al. Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. , 2008, Virology.
[42] Chi-Huey Wong,et al. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN , 2008, Proceedings of the National Academy of Sciences.
[43] Peter B Gilbert,et al. Genome scanning tests for comparing amino acid sequences between groups. , 2008, Biometrics.
[44] B. Korber,et al. Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing , 2008, Journal of Virology.
[45] B. Berkhout,et al. The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion , 2008, Retrovirology.
[46] M. Churchill,et al. Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS , 2007, Retrovirology.
[47] L. Morris,et al. The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection , 2007, Journal of Virology.
[48] Simon Easteal,et al. Mind the gaps: evidence of bias in estimates of multiple sequence alignments. , 2007, Molecular biology and evolution.
[49] Mark Connors,et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies , 2007, Nature Medicine.
[50] Jiyang Jiang,et al. Maturation-Dependent Human Immunodeficiency Virus Type 1 Particle Fusion Requires a Carboxyl-Terminal Region of the gp41 Cytoplasmic Tail , 2007, Journal of Virology.
[51] David Heckerman,et al. Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 , 2007, PLoS pathogens.
[52] S Gnanakaran,et al. Clade-Specific Differences between Human Immunodeficiency Virus Type 1 Clades B and C: Diversity and Correlations in C3-V4 Regions of gp120 , 2007, Journal of Virology.
[53] Hui Li,et al. Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection , 2007, Journal of Virology.
[54] Douglas D. Richman,et al. Dissecting the Neutralizing Antibody Specificities of Broadly Neutralizing Sera from Human Immunodeficiency Virus Type 1-Infected Donors , 2007, Journal of Virology.
[55] D. Heckerman,et al. Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.
[56] S. Gnanakaran,et al. Unique Mutational Patterns in the Envelope α2 Amphipathic Helix and Acquisition of Length in gp120 Hypervariable Domains Are Associated with Resistance to Autologous Neutralization of Subtype C Human Immunodeficiency Virus Type 1 , 2007, Journal of Virology.
[57] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[58] V. KewalRamani,et al. Dendritic-cell interactions with HIV: infection and viral dissemination , 2006, Nature Reviews Immunology.
[59] H. Katinger,et al. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity , 2006, AIDS.
[60] Robin Shattock,et al. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? , 2006, Nature Reviews Microbiology.
[61] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[62] P. Harrigan,et al. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. , 2005, The Journal of infectious diseases.
[63] Yang Liu,et al. Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B , 2005, Journal of Virology.
[64] Dorothy M. Lang,et al. Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels , 2005, Journal of Virology.
[65] R. Swanstrom,et al. Multiple V1/V2 env Variants Are Frequently Present during Primary Infection with Human Immunodeficiency Virus Type 1 , 2004, Journal of Virology.
[66] L. Stamatatos,et al. N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies , 2004, Journal of Virology.
[67] Bette T. Korber,et al. Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission , 2004, Science.
[68] Steven Salzberg,et al. On Comparing Classifiers: Pitfalls to Avoid and a Recommended Approach , 1997, Data Mining and Knowledge Discovery.
[69] Yoshua Bengio,et al. Série Scientifique Scientific Series No Unbiased Estimator of the Variance of K-fold Cross-validation No Unbiased Estimator of the Variance of K-fold Cross-validation , 2022 .
[70] Michael P Busch,et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.
[71] Remco R. Bouckaert,et al. Choosing Between Two Learning Algorithms Based on Calibrated Tests , 2003, ICML.
[72] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[73] R. Benarous,et al. Targeting of the Human Immunodeficiency Virus Type 1 Envelope to the trans-Golgi Network through Binding to TIP47 Is Required for Env Incorporation into Virions and Infectivity , 2003, Journal of Virology.
[74] I. Braakman,et al. Folding of HIV‐1 Envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation‐dependent leader peptide cleavage , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[76] S. Sarkar,et al. Rational Site-Directed Mutations of the LLP-1 and LLP-2 Lentivirus Lytic Peptide Domains in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41 Indicate Common Functions in Cell-Cell Fusion but Distinct Roles in Virion Envelope Incorporation , 2003, Journal of Virology.
[77] Tuofu Zhu,et al. Virus Population Homogenization following Acute Human Immunodeficiency Virus Type 1 Infection , 2002, Journal of Virology.
[78] H. Katinger,et al. The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 , 2002, Journal of Virology.
[79] Peter D. Kwong,et al. The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 , 2002, Journal of Virology.
[80] Feng Gao,et al. Diversity Considerations in HIV-1 Vaccine Selection , 2002, Science.
[81] Susan Zolla-Pazner,et al. Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein , 2002, Journal of Virology.
[82] I. Braakman,et al. Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. , 2001, Biochimie.
[83] William C. Olson,et al. Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 Complexes , 2001, Journal of Virology.
[84] J. Haas,et al. Identification of Two Sequences in the Cytoplasmic Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Inhibit Cell Surface Expression , 2001, Journal of Virology.
[85] H. Ploegh,et al. Signal peptide cleavage of a type I membrane protein, HCMV US11, is dependent on its membrane anchor , 2001, The EMBO journal.
[86] C. A. Derdeyn,et al. Mutational Analysis of Conserved Domains within the Cytoplasmic Tail of gp41 from Human Immunodeficiency Virus Type 1: Effects on Glycoprotein Incorporation and Infectivity , 2000, Journal of Virology.
[87] W A Hendrickson,et al. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. , 2000, Structure.
[88] L. Stamatatos,et al. V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies , 2000, Journal of Virology.
[89] A. Lapedes,et al. Timing the ancestor of the HIV-1 pandemic strains. , 2000, Science.
[90] J. Sodroski,et al. Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120. , 2000, AIDS research and human retroviruses.
[91] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[92] E. Freed,et al. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[93] J. Margolick,et al. Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[94] Ying Sun,et al. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. , 1998, Science.
[95] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[96] R. Means,et al. A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.
[97] L. Kasturi,et al. The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency. , 1998, Biochemistry.
[98] R. Tibshirani,et al. Improvements on Cross-Validation: The 632+ Bootstrap Method , 1997 .
[99] Y. Shai,et al. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. , 1997, Biochemistry.
[100] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[101] Huaiyu Zhu,et al. No Free Lunch for Cross-Validation , 1996, Neural Computation.
[102] D. Y. Thomas,et al. Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[103] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[104] Ron Kohavi,et al. A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.
[105] Sean R. Eddy,et al. Multiple Alignment Using Hidden Markov Models , 1995, ISMB.
[106] D. Y. Thomas,et al. Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. , 1994, Virology.
[107] B. Walker,et al. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays , 1994, Journal of virology.
[108] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[109] G. Norkrans,et al. HIV type 1 V3 sequence diversity in contact-traced Swedish couples at the time of sexual transmission. , 1994, AIDS research and human retroviruses.
[110] M. Sitbon,et al. Conserved framework of envelope glycoproteins among lentiviruses. , 1994, Current topics in microbiology and immunology.
[111] D. Ho,et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.
[112] E. Holmes,et al. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.
[113] M. Sitbon,et al. Functional tolerance of the human immunodeficiency virus type 1 envelope signal peptide to mutations in the amino-terminal and hydrophobic regions , 1992, Journal of virology.
[114] J. Goudsmit,et al. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. , 1992, Virology.
[115] B. Korber,et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. , 1992, Science.
[116] Jon Beckwith,et al. The role of charged amino acids in the localization of secreted and membrane proteins , 1990, Cell.
[117] R. Swanstrom,et al. Retrovirus envelope glycoproteins. , 1990, Current topics in microbiology and immunology.
[118] J. Felsenstein. Phylogenies and the Comparative Method , 1985, The American Naturalist.
[119] G. Heijne. Analysis of the distribution of charged residues in the N‐terminal region of signal sequences: implications for protein export in prokaryotic and eukaryotic cells. , 1984, The EMBO journal.
[120] G. von Heijne. Analysis of the distribution of charged residues in the N-terminal region of signal sequences: implications for protein export in prokaryotic and eukaryotic cells. , 1984, The EMBO journal.
[121] B. Efron. Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation , 1983 .
[122] K. R. Woods,et al. A computer program for predicting protein antigenic determinants. , 1983, Molecular immunology.
[123] M. Stone. Asymptotics for and against cross-validation , 1977 .